110 related articles for article (PubMed ID: 21169053)
1. Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance.
Iyer A; Rajendran V; Adamson CS; Peng Z; Cooper K; Evans MF
J Clin Virol; 2011 Mar; 50(3):205-8. PubMed ID: 21169053
[TBL] [Abstract][Full Text] [Related]
2. Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: is HPV the common denominator?
Rajendra S; Robertson IK
J Clin Pathol; 2010 Jan; 63(1):1-3. PubMed ID: 20026700
[No Abstract] [Full Text] [Related]
3. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event.
Rai N; Jenkins GJ; McAdam E; Hibbitts SJ; Fiander AN; Powell NG
J Clin Virol; 2008 Oct; 43(2):250-2. PubMed ID: 18718811
[TBL] [Abstract][Full Text] [Related]
5. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
[TBL] [Abstract][Full Text] [Related]
6. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
[TBL] [Abstract][Full Text] [Related]
7. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
Antonsson A; Knight L; Whiteman DC;
Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus.
Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
[TBL] [Abstract][Full Text] [Related]
11. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim R; Weissfeld JL; Reynolds JC; Kuller LH
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
[TBL] [Abstract][Full Text] [Related]
12. Barrett's oesophagus; acid and the human papilloma virus?
Rajendra S; Robertson IK
J Clin Virol; 2009 Feb; 44(2):176. PubMed ID: 19119064
[No Abstract] [Full Text] [Related]
13. Viral load and integration status of high-risk human papillomaviruses in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Wang B; Rajendra S; Pavey D; Sharma P; Merrett N; Wu X; Snow ET; Kumbhari V; Ball MJ; Robertson IK
Am J Gastroenterol; 2013 Nov; 108(11):1814-6. PubMed ID: 24192963
[No Abstract] [Full Text] [Related]
14. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
15. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review.
Kunzmann AT; Graham S; McShane CM; Doyle J; Tommasino M; Johnston B; Jamison J; James JA; McManus D; Anderson LA
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):817-825. PubMed ID: 28252462
[TBL] [Abstract][Full Text] [Related]
17. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
18. Esophageal squamous carcinoma in five patients with Barrett's esophagus.
Paraf F; Fléjou JF; Potet F; Molas G; Fékété F
Am J Gastroenterol; 1992 Jun; 87(6):746-50. PubMed ID: 1590313
[TBL] [Abstract][Full Text] [Related]
19. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
[TBL] [Abstract][Full Text] [Related]
20. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
Sato T; Miwa K; Sahara H; Segawa M; Hattori T
Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
